These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30791781)

  • 1. Cholesterol cholelithiasis: part of a systemic metabolic disease, prone to primary prevention.
    Di Ciaula A; Wang DQ; Portincasa P
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):157-171. PubMed ID: 30791781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in understanding and managing cholesterol gallstones.
    Di Ciaula A; Portincasa P
    F1000Res; 2018; 7():. PubMed ID: 30345010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones.
    Jüngst D; Brenner G; Pratschke E; Paumgartner G
    J Hepatol; 1989 Jan; 8(1):1-6. PubMed ID: 2921499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol cholelithiasis in pregnant women: pathogenesis, prevention and treatment.
    de Bari O; Wang TY; Liu M; Paik CN; Portincasa P; Wang DQ
    Ann Hepatol; 2014; 13(6):728-45. PubMed ID: 25332259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Inhibition of Intestinal Cholesterol Absorption on the Prevention of Cholesterol Gallstone Formation.
    Portincasa P; Wang DQ
    Med Chem; 2017; 13(5):421-429. PubMed ID: 28185534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary and secondary prevention of gallstone disease: implications for patient management and research priorities.
    Hofmann AF
    Am J Surg; 1993 Apr; 165(4):541-8. PubMed ID: 8386910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triglycerides and gallstone formation.
    Smelt AH
    Clin Chim Acta; 2010 Nov; 411(21-22):1625-31. PubMed ID: 20699090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of hypolipidemic treatment on the composition of bile and the risk or cholesterol gallstone disease].
    Zák A; Zeman M; Hrubant K; Vecka M; Tvrzická E
    Cas Lek Cesk; 2007; 146(1):24-34. PubMed ID: 17310581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on the pathogenesis of cholesterol gallstone disease.
    Di Ciaula A; Wang DQ; Portincasa P
    Curr Opin Gastroenterol; 2018 Mar; 34(2):71-80. PubMed ID: 29283909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in bile composition during gallstone formation in hamsters.
    Yanaura S; Iizuka A
    J Pharmacobiodyn; 1981 Oct; 4(10):820-2. PubMed ID: 7198683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling plasma lipoprotein-bile lipid relationships: differential impact of psyllium and cholestyramine in hamsters fed a lithogenic diet.
    Trautwein EA; Siddiqui A; Hayes KC
    Metabolism; 1993 Dec; 42(12):1531-40. PubMed ID: 8246766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile acids substituted in the 6 position prevent cholesterol gallstone formation in the hamster.
    Cohen BI; Matoba N; Mosbach EH; Ayyad N; Hakam K; Suh SO; McSherry CK
    Gastroenterology; 1990 Feb; 98(2):397-405. PubMed ID: 2295395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lactulose and fiber-rich diets on bile in relation to gallstone disease: an update.
    VanBerge-Henegouwen GP; Portincasa P; van Erpecum KJ
    Scand J Gastroenterol Suppl; 1997; 222():68-71. PubMed ID: 9145452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of chenodeoxycholic acid and dietary cholesterol in the treatment of cholesterol gallstones.
    Doty JE; DenBesten L; Roslyn JJ; Pitt HA; Kuchenbecker SL; Porter-Fink V
    Am J Surg; 1982 Jan; 143(1):48-54. PubMed ID: 7053655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chenodeoxycholic and ursodeoxycholic acids on lipid metabolism and gallstone formation in the prairie dog.
    Cohen BI; Singhal AK; Stenger RJ; May-Donath P; Finver-Sadowsky J; McSherry CK; Mosbach EH
    Hepatology; 1984; 4(2):300-7. PubMed ID: 6706304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary lipid output and bile acid kinetics in cholesterol gallstone disease. Evidence for an increased hepatic secretion of cholesterol in Swedish patients.
    Nilsell K; Angelin B; Liljeqvist L; Einarsson K
    Gastroenterology; 1985 Aug; 89(2):287-93. PubMed ID: 4007420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy of gallstone disease: What it was, what it is, what it will be.
    Portincasa P; Ciaula AD; Bonfrate L; Wang DQ
    World J Gastrointest Pharmacol Ther; 2012 Apr; 3(2):7-20. PubMed ID: 22577615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postdissolution gallstone recurrence. A clinical perspective.
    Thistle JL
    Dig Dis Sci; 1989 Dec; 34(12 Suppl):44S-48S. PubMed ID: 2598767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired biliary cholesterol secretion and decreased gallstone formation in apolipoprotein E-deficient mice fed a high-cholesterol diet.
    Amigo L; Quiñones V; Mardones P; Zanlungo S; Miquel JF; Nervi F; Rigotti A
    Gastroenterology; 2000 Apr; 118(4):772-9. PubMed ID: 10734029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of cholesterol monohydrate crystals in gallbladder and hepatic bile in man: influence of bile acid treatment.
    Sahlin S; Ahlberg J; Angelin B; Ewerth S; Nilsell K; Reihnér E; Einarsson K
    Eur J Clin Invest; 1988 Aug; 18(4):386-90. PubMed ID: 3139424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.